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Neuronal ceroid lipofuscinosis (NCL), also known as Batten disease, is a debilitating neurological disorder that affects
both children and adults. Thirteen genetically distinct genes have been identified that when mutated, result in
abnormal lysosomal function and an excessive accumulation of ceroid lipofuscin in neurons, as well as other cell types
outside of the central nervous system. The NCL family of proteins is comprised of lysosomal enzymes (PPT1/CLN1,
TPP1/CLN2, CTSD/CLN10, CTSF/CLN13), proteins that peripherally associate with membranes (DNAJC5/CLN4, KCTD7/
CLN14), a soluble lysosomal protein (CLN5), a protein present in the secretory pathway (PGRN/CLN11), and several
proteins that display different subcellular localizations (CLN3, CLN6, MFSD8/CLN7, CLN8, ATP13A2/CLN12).
Unfortunately, the precise functions of many of the NCL proteins are still unclear, which has made targeted therapy
development challenging. The social amoeba Dictyostelium discoideum has emerged as an excellent model system for
studying the normal functions of proteins linked to human neurological disorders. Intriguingly, the genome of this
eukaryotic soil microbe encodes homologs of 11 of the 13 known genes linked to NCL. The genetic tractability of the
organism, combined with its unique life cycle, makes Dictyostelium an attractive model system for studying the
functions of NCL proteins. Moreover, the ability of human NCL proteins to rescue gene-deficiency phenotypes in
Dictyostelium suggests that the biological pathways regulating NCL protein function are likely conserved from
Dictyostelium to human. In this review, I will discuss each of the NCL homologs in Dictyostelium in turn and describe
how future studies can exploit the advantages of the system by testing new hypotheses that may ultimately lead to
effective therapy options for this devastating and currently untreatable neurological disorder.
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Background
Dictyostelium as a model system for studying human
neurological disorders
The social amoeba Dictyostelium discoideum is a fascin-
ating microbe that has emerged as a valuable model or-
ganism for biomedical and human disease research. This
model eukaryote, which has historically been used to
study basic cell function and multicellular development,
undergoes a 24-h asexual life cycle comprised of both
single-cell and multicellular phases [1] (Fig. 1). As a re-
sult, it is an excellent system for studying a variety of
cellular and developmental processes, including
lysosome function and intracellular trafficking and sig-
nalling [2, 3]. In nature, Dictyostelium feeds and grows
as single cells (Fig. 1). When prompted by starvation,
cells undergo chemotactic aggregation towards cAMP to
form a multicellular aggregate (i.e., a mound), which
then undergoes a series of morphological changes to
form a motile multicellular pseudoplasmodium, also re-
ferred to as a slug (Fig. 1). Cells within the slug then ter-
minally differentiate into either stalk or spore to form a
fruiting body [4] (Fig. 1). Unlike immortalized mamma-
lian cells that have been removed from their respective
tissues, Dictyostelium represents a true organism in the
cellular state that retains all of its dynamic physiological
processes. Moreover, the cellular processes and signal-
ling pathways that regulate the behaviour of
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Dictyostelium cells are remarkably similar to those ob-
served in metazoan cells, indicating that findings from
Dictyostelium are highly likely to be translatable to more
complex eukaryotic systems [5].
Dictyostelium is recognized as an excellent model system
for studying human neurological disorders, including epi-
lepsy, lissencephaly, Parkinson’s disease, Alzheimer’s dis-
ease, and Huntington’s disease [6–10]. Dictyostelium also
contains the highest content of prion-like proteins of all
organisms investigated to date [11, 12]. Intriguingly, prion-
like proteins known to generate insoluble deposits in other
eukaryotic cells, do not aggregate in Dictyostelium [11, 12].
Instead these proteins accumulate in the nucleus and are
broken down by the ubiquitin–proteasome system suggest-
ing that Dictyostelium has undergone specific adaptations
that allow it to efficiently regulate its prion-like proteome
[11, 12]. Thus, understanding the pathways involved in pre-
venting protein aggregation in Dictyostelium could provide
novel routes to tackling neurological disorders character-
ized by protein aggregation (e.g., Alzheimer’s, Parkinson’s,
and Huntington’s disease).
Dictyostelium as a model system for studying neuronal
ceroid lipofuscinosis
Recently, Dictyostelium has emerged as a significant
model system for studying neuronal ceroid lipofuscinosis
(NCL) [13–15]. NCL, also known as Batten disease, is a
neurological disorder that affects both children and adults
[16]. The disease, which is the most common form of neu-
rodegeneration in children, affects all ethnicities world-
wide. The highest rates of incidence are observed in
Northern European populations and Newfoundland,
Canada [17–20]. Over 430 mutations have been docu-
mented in thirteen genetically distinct NCL genes, which
are categorized based on the age of onset and pathological
features [16, 21, 22] (Table 1). However, more genes likely
remained to be identified as some patients who present
with NCL-like symptoms do not carry mutations in any of
the known NCL genes. Clinical manifestations of the dis-
ease include the progressive loss of vision, mental ability,
and motor function, as well as epileptic seizures and a re-
duced lifespan [23]. At the cellular level, NCL disorders
characteristically display aberrant lysosomal function and
an excessive accumulation of ceroid lipofuscin in neurons
and other cell types, with pathology often seen outside of
the central nervous system [22].
Substantial molecular advances have been made in the
past decade, which has made a significant impact on
genetic diagnosis and our understanding of the biology
underlying the NCL disorders. The NCL family of pro-
teins is comprised of lysosomal enzymes (PPT1/CLN1,
TPP1/CLN2, CTSD/CLN10, CTSF/CLN13), proteins
that peripherally associate with membranes (DNAJC5/
CLN4, KCTD7/CLN14), a soluble lysosomal protein
Fig. 1 The life cycle of Dictyostelium. During growth, single cells feed on bacteria. Upon starvation, cells undergo chemotactic aggregation towards
cAMP to form a multicellular mound. The mound then forms a finger, which falls on the surface to generate a motile pseudoplasmodium, or slug.
During culmination, terminal differentiation of pre-stalk and pre-spore cells forms a fruiting body composed of a mass of viable spores supported atop
a slender stalk. When a food source becomes available, the spores germinate allowing the cells to restart the life cycle
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(CLN5), a protein that is present in the secretory path-
way (PGRN/CLN11), and several transmembrane pro-
teins that display different subcellular localizations
(CLN3, CLN6, MFSD8/CLN7, CLN8, ATP13A2/CLN12)
[16, 21]. Unfortunately, the precise functions of many of
the NCL proteins are still unknown [21]. As a result,
new innovative approaches are critically needed to iden-
tify the primary functions of these proteins, which will
hopefully lead to targeted therapy development for this
devastating and currently untreatable disease. Interest-
ingly, recent genetic advances now clearly support a
strong overlap of NCL phenotypes with later onset neu-
rodegenerative diseases, including Parkinson’s and fron-
totemporal dementia [24, 25]. Therefore, studying the
cellular mechanisms underlying NCL protein function
may provide fresh new insight into these and other re-
lated neurological disorders.
Homologs of NCL proteins have been identified and
studied in several model organisms and this work has sig-
nificantly enhanced our understanding of the localization
and functions of NCL proteins in humans [26–28]. The
Dictyostelium genome contains homologs of 11 of the 13
known NCL genes, but does not contain homologs of
CLN6 or CLN8 (Table 2). Of all the NCL proteins, these





DNAJC5/CLN4 Adult-onset NCL, Kufs disease, Parry disease
CLN5 Late-infantile NCL (Finnish variant)
CLN6 Variant late-infantile NCL
MFSD8/CLN7 Late-infantile NCL (Turkish variant)
CLN8 Northern epilepsy (epilespy, progressive with
mental retardation, EPMR)
CTSD/CLN10 Congenital, neonatal and late infantile NCL





Table 2 Dictyostelium proteins homologous to human NCL proteins
Human protein Size (aa) Dictyostelium homolog (dictyBase ID) Size (aa) Region of similarity (aa) Identities (%) Positives (%) E-value
PPT1/CLN1
Accession: NP_000301
306 Ppt1 (DDB0233890) 303 273 46 69 8.00E-80
TPP1/CLN2
Accession: NP_000382
563 Tpp1 (DDB0234303) 600 552 36 52 4.00E-91
CLN3
Accession: NP_000077
438 Cln3 (DDB0233983) 421 429 27 45 3.00E-31
DNAJC5/CLN4
Accession: NP_079495
198 Ddj1 (DDB0215016) 411 69 57 76 2.00E-18
CLN5
Accession: NP_006484












412 CtsD (DDB0215012) 383 359 47 66 9.00E-91
PGRN/CLN11
Accession: NP_002078
593 Grn (DDB0238428) 130 47 55 68 2.00E-08
ATP13A2/CLN12
Accession: NP_071372
1180 Kil2 (DDB0237611) 1158 1089 35 53 1.00E-175
CTSF/CLN13
Accession: NP_003784
484 CprA (DDB0201647) 343 340 37 55 6.00E-64
KCTD7/CLN14
Accession: NP_694578
289 Kctd9 (DDB0231824) 488 96 38 58 2.00E-11
The amino acid sequences of human NCL proteins were inputted into the BLASTp server of dictyBase (http://www.dictybase.org). The following parameters were
set: E-value, 1000; Matrix, BLOSUM62; Filter, no
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are the only ER-resident membrane proteins [29, 30]. By
comparison, Dictyostelium contains more homologs of
NCL proteins than other model organisms including bud-
ding and fission yeast, the nematode Caenorhabditis ele-
gans, and the fruit fly Drosophila melanogaster, but fewer
than zebrafish (Danio rerio) [26–28] (Table 3). While the
functions of some of the homologs in Dictyostelium have
been investigated using gene-deficiency models, knockout
mutants for several of the genes have yet to be generated
(e.g., ppt1/cln1, ddj1/cln4, cln5, mfsd8/cln7, grn/cln11,
cprA/cln13). Moreover, of the genes that have been stud-
ied, many have not been investigated in relation to NCL
(e.g., ctsD/cln10, kil2/cln12, kctd9/cln14). The mRNA ex-
pression profiles of the Dictyostelium NCL homologs sug-
gest different roles during the life cycle, with some being
required for growth, and others for development [31]
(Fig. 2). Moreover, many of the NCL homologs were de-
tected in a proteomic profile of the macropinocytic path-
way suggesting that the proteins share common functions
or participate in the same biological pathway or process
[32]. In this review, I will discuss each of the NCL homo-
logs in Dictyostelium in turn, and highlight how we can
use this model organism to provide fresh new insight into
NCL protein function. While the focus of this review will
be on the Dictyostelium homologs of human TPP1/CLN2,
CLN3, CTSD/CLN10, ATP13A2/CLN12, CTSF/CLN13,
and KCTD7/CLN14, the potential to use Dictyostelium to
elucidate the functions of the other NCL proteins will also
be discussed.
Ppt1, the Dictyostelium homolog of human PPT1/CLN1
Mutations in palmitoyl-protein thioesterase 1 (PPT1/
CLN1) cause one of the two infantile forms of NCL and
the most severe subtype of the disease [21, 23] (Table 1).
Clinical symptoms present between the ages of 1 and 2,
and usually results in death between the ages of 8 and
11 [33]. However late infantile, juvenile, and adult forms
of this NCL subtype have also been reported [34–38].
The PPT1 gene is conserved from yeast to human [26–28]
(Table 3). PPT1 localizes to the lysosomal matrix, cyto-
plasmic vesicles, the endoplasmic reticulum (ER), lipid
rafts, and presynaptic areas in neurons [21] (Table 4). The
targets of PPT1-mediated de-palmitoylation and the
precise function of the protein are still not known, how-
ever the protein is thought to be involved in apoptosis,
Table 3 Established and putative homologs of NCL proteins in other model organisms
Human Protein S. cerevisiae (budding yeast)
S. pombe (fission yeast)
C. elegans (nematode) D. melanogaster (fruit fly) D. rerio (zebrafish)
PPT1/CLN1
Accession: NP_000301
Yes (S. pombe) [26–28] Yes [26] Yes [26–28] Yes [27, 28]
TPP1/CLN2
Accession: NP_000382
No No No Yes [27, 28]
CLN3
Accession: NP_000077
Yes [26–28] Yes [26–28] Yes [26–28] Yes [27, 28]
DNAJC5/CLN4
Accession: NP_079495
Yes [a] Yes [28] Yes [c] Yes [27, 28]
CLN5
Accession: NP_006484
No No No Yes [27, 28]
CLN6
Accession: NP_060352
No No No Yes [27, 28]
MFSD8/CLN7
Accession: NP_689991
No Yes [b] Yes [27, 28] Yes [27, 28]
CLN8
Accession: NP_061764
No No No Yes [27, 28]
CTSD/CLN10
Accession: NP_001900
Yes [26–28] Yes [26, 28] Yes [26–28] Yes [27, 28]
PGRN/CLN11
Accession: NP_002078
No Yes [b] No Yes [27, 28]
ATP13A2/CLN12
Accession: NP_071372
Yes [28],[a] Yes [b] Yes [c] Yes [27, 28]
CTSF/CLN13
Accession: NP_003784
No Yes [b] Yes [c] Yes [27, 28]
KCTD7/CLN14
Accession: NP_694578
No Yes [b] Yes [c] Yes [27, 28]
The information contained within this table is described in detail elsewhere [26–28]. The presence and absence of homologs in each organism was confirmed
with NCBI BLASTp [a], WormBase BLASTp [b], and FlyBase BLASTp [c]
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cholesterol metabolism, and the recycling of synaptic
vesicles [21] (Table 5).
The Dictyostelium homolog of human PPT1, ppt1, is
composed of three exons that encode a 303 amino acid,
34 kDa protein (Ppt1; DDB0233890) (Table 2). Like
PPT1, the Dictyostelium homolog contains a signal pep-
tide for secretion suggesting that it may function extra-
cellularly (SignalP 4.0) [39]. Not surprisingly, the enzyme
has been detected in the macropinocytic pathway of Dic-
tyostelium as well as in conditioned media from develop-
ing cells [32, 40] (Table 4). ppt1 expression increases
during the early stages of development and reaches its
peak level after 8 h [31] (Fig. 2b). Expression then de-
creases dramatically during mid-stage development and
remains low during terminal differentiation and fruiting
body formation (Fig. 2b). These results suggest that Ppt1
may be important for processes that occur during the
early stages of development, specifically cAMP chemo-
taxis and aggregation. A knockout mutant has not yet
been generated to study the function of Ppt1 in
Dictyostelium. However, a previous study that analyzed
genome-wide transcriptional changes during bacterial
feeding and growth suggests that Ppt1 may function dur-
ing phagocytosis, which supports data from mice linking
PPT1 function to phagocyte infiltration following neur-
onal cell death [41, 42] (Table 5).
Tpp1, the Dictyostelium homolog of human TPP1/CLN2
Mutations in tri-peptidyl peptidase 1 (TPP1/CLN2)
cause a late infantile form of NCL [21, 23] (Table 1).
Clinical symptoms present between the ages of 2 and 4,
with death typically occurring between the ages of 6 and
15 [43]. In addition to NCL, mutations in TPP1 have
also been linked to autosomal recessive spinocerebellar
ataxia 7 (SCAR7) [44]. The TPP1 protein localizes to the
lysosomal matrix and the ER, functions as a serine pro-
tease, and has been linked to endocytosis, macroauto-
phagy, and TNF-α-induced apoptosis [21] (Tables 4 and
5). While TPP1 is highly conserved in vertebrates, ho-
mologs are not present in classical model organisms
Fig. 2 Gene expression analysis of NCL homologs in Dictyostelium. RNA-Seq data was obtained from dictyExpress (http://www.dictyexpress.biolab.si)
[31] and re-plotted using Microsoft Excel. Genes with similar magnitudes of scaled read counts were grouped together on the same plot. a Expression
profiles of all NCL homologs. b Expression profiles of ppt1, cln3, mfsd8, grn, kil2, kctd9. c Expression profiles of tpp1, ddj1, and cln5. d Expression profiles
of ctsD and cprA. e Timeline of the various stages of Dictyostelium development. Images are not drawn to scale
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such as yeast, the nematode, and the fruit fly [45]
(Table 3). As a result, the NCL research community has
been unable to exploit the relative advantages of these sys-
tems to study TPP1 function. Fortunately, the Dictyoste-
lium genome encodes a homolog of TPP1 which was
recently characterized [14]. The Dictyostelium homolog,
tpp1, is composed of one exon that encodes a 600 amino
acid, 67 kDa protein (Tpp1; DDB0234303) (Table 2). Tpp1
contains peptidase S8 and S53 domains as well as a putative
signal peptide for secretion (SignalP 4.0) [39]. However the
protein has not been detected in conditioned media from
developing Dictyostelium cells [40]. tpp1 expression in-
creases during the early-to-mid stages of development
reaching peak levels after 16 h [31] (Fig. 2c). Expression
then decreases dramatically during the later stages of devel-
opment (Fig. 2c). The function of the protein, which is
enriched in pre-spore cells, was recently characterized [14,
46]. Importantly, Dictyostelium Tpp1 shares many attri-
butes with human TPP1. As in human cells, Dictyostelium
Tpp1 localizes to the lysosome [14, 22] (Table 4). Auto-
fluorescent bodies are observed in Dictyostelium tpp1− cells
during mid-stage development, which is similar to the
auto-fluorescent material observed in human cells express-
ing mutated TPP1 [14, 22]. However the composition of
the aggregated material in Dictyostelium cells remains to be
identified. tpp1− cells develop precociously and show a re-
duced ability to cleave target substrates and form spores
[14] (Table 5). Similar to phenotypes observed in mamma-
lian cell models, Tpp1-deficient cells also show defects in
autophagy [14] (Table 5). More specifically, in response to
starvation, tpp1− cells display reduced cell size and viabil-
ity when compared to wild-type [14]. In support of its
localization to the lysosome, Tpp1-deficienct cells display
strongly impaired development when treated with the
lysosome-perturbing drug chloroquine [14]. Importantly,
Phillips and Gomer [14] showed that this phenotype can
be suppressed by a secondary mutation in stpA (suppres-
sor of Tpp1, DDB_G0282973), which encodes a protein
that shares some sequence similarity to mammalian
oxysterol-binding proteins. This finding indicates that Dic-
tyostelium has the potential to make substantial contribu-
tions to NCL protein research, specifically by exploiting
the genetic tractability of the organism to identify other
secondary mutations that suppress NCL phenotypes.
Cln3, the Dictyostelium homolog of human CLN3
The most common subtype of NCL is caused by loss-of-
function mutations in ceroid lipofuscinosis neuronal 3
(CLN3), which is one of the two juvenile forms of the dis-
ease [21, 23] (Table 1). Clinical symptoms present between
Table 4 Localization of NCL homologs in Dictyostelium and other systems
Dictyostelium homolog dictyBase ID Localization in Dictyostelium Localization of human protein (or homologs in other systems)






Presynaptic areas in neurons [21]
Tpp1 DDB0234303 Lysosome [14] Endoplasmic reticulum [21]
Lysosomal matrix [21]
Cln3 DDB0233983 CV system [13, 15]
Endocytic pathway [13, 15]
Macropinocytic pathway [32]
Late endosomal membrane [21]
Lysosomal membrane [21]






Synaptic vesicles in neurons [21]
Secretory granules in endocrine, neurocrine and exocrine cells [21]
Vesicular membranes [21]
Cln5 DDB0234077 Macropinocytic pathway [32] Extracellular space [76]
Lysosomal matrix [21, 75]
Mfsd8 DDB0307149 Macropinocytic pathway [32] Lysosomal membrane [21]
CtsD DDB0215012 Endocytic pathway (e.g., phagosome,
lysosome) [81–83]
Macropinocytic pathway [32]
Extracellular space [21, 79, 80]
Lysosomal matrix [21]
Grn DDB0238428 Not known Extracellular space [21, 97]
Kil2 DDB0237611 Macropinocytic pathway [32]
Phagosomal membrane [102]
Lysosomal membrane [21, 99, 100]
Multi-vesicular bodies [21, 99, 100]
CprA DDB0201647 Not known Lysosomal matrix [21]
Kctd9 DDB0231824 Not known Cell membrane [21, 114]
Punctate cytoplasmic distributions [21, 114]
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the ages of 5 and 10 and result in premature death usually
in the late teenage years or early 20s [22, 33]. The human
CLN3 gene encodes a 438 amino acid multi-pass trans-
membrane protein that is predicted to contain 6 transmem-
brane domains [47]. The gene is conserved from yeast to
human and has been studied using a number of systems
and cell models [26–28] (Table 3). The CLN3 protein,
which localizes to late endosomes and the lysosomal mem-
brane, has been linked to autophagy, apoptosis, intracellular
trafficking, lysosomal pH homeostasis, cell cycle control,
osmoregulation, and calcium homeostasis [21] (Tables 4
and 5). However, the precise function of CLN3 and the
mechanism by which the protein affects these processes re-
mains unknown [26–28].
The Dictyostelium homolog, cln3, is composed of three
exons that encode a 421 amino acid, 47 kDa protein (Cln3;
DDB0233983) predicted to contain 10–11 transmembrane
domains (Table 2). Importantly, amino acid residues that
are post-translationally modified in human CLN3 are con-
served in the Dictyostelium homolog, as are residues
Table 5 Cellular processes modulated by NCL homologs in Dictyostelium and other systems
Dictyostelium homolog dictyBase ID Processes modulated in Dictyostelium Knockout mutant
generated
Processes modulated by human protein
(or homologs in other systems)
Ppt1 DDB0233890 Phagocytosis [41] No Apoptosis [21]
Cholesterol metabolism [21]
Phagocytosis [42]
Recycling of synaptic vesicles [21]
Tpp1 DDB0234303 Autophagy [14]
Pre-spore cell differentiation [14]
Timing of mid-stage development
[14]
Yes [14] Endocytosis [21] Macroautophagy [21]
TNF-α-induced apoptosis [21]
Cln3 DDB0233983 Cell proliferation [13]
Pinocytosis [13]
Protein secretion and cleavage [13]
Cell adhesion [15]
Timing of mid-stage development
[15]
Timing of late-stage development
[15]
Response to bacterial pathogens [66]
Yes [13] Apoptosis [21]
Autophagy [21]
Calcium homeostasis [21]
Cell cycle control [21]
Endocytosis [21]
Intracellular trafficking [21] Lysosomal pH
homeostasis [21]
Osmoregulation [21]
Ddj1 DDB0215016 Phagocytosis [70] No Presynaptic endocytosis and exocytosis [21]
Cln5 DDB0234077 Not known No Apoptosis [21]
Cell growth [21]
Myelination [21]
Sorting and recycling of lysosomal receptors [21]
Sphingolipid transport and synthesis [21]
Mfsd8 DDB0307149 Not known No Predicted to have a role in:
Transport of small substrates across the lysosomal
membrane [21]
CtsD DDB0215012 Bacterial killing [86]
Cell death [88, 89]
Timing of early-stage development
[81]
Yes [79] Apoptosis [21, 90]
Autophagy [21, 91]
Cell migration [85]
Innate immune response [87]
Grn DDB0238428 Not known No Autophagy [21, 97]




Kil2 DDB0237611 Bacterial killing [102, 105]
Predation on yeast [104]
Yes [100] Predicted to have a role in:
Lysosomal degradation [21]
pH and biometal homeostasis within lysosomes [21]
Transport across cellular membranes [21]
CprA DDB0201647 Early-stage development [108]
Osmoregulation [110]
No Autophagy [21]
Cell immunity [21, 113]
Lipoprotein degradation [21]
Proteasome degradation [21]
Kctd9 DDB0231824 Not known Yes [118] Predicted to have a role in:
Hyperpolarization of the neuronal cell membrane
[21]
Proteasome degradation [21]
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mutated in patients with the disease [13]. cln3 expression
increases dramatically during the early stages of develop-
ment reaching peak levels after 12 h [31] (Fig. 2b). Expres-
sion then remains high during the mid-to-late stages of
development (Fig. 2b). Loss of Cln3 results in aberrant se-
cretion and cleavage of autocrine proliferation repressor A
(AprA) and counting factor-associated protein A (CfaD)
during growth [13]. As a consequence, Cln3-deficient cells
display an increased rate of proliferation compared to wild-
type [13] (Table 5). During the early stages of development,
the aggregation of cln3− cells is delayed and aberrant, but
this phenotype is not due to reduced chemotaxis, alter-
ations in the expression or localization of the cAMP recep-
tor (CarA), or aberrant expression of genes linked to cAMP
signal transduction [15] (Table 5). However, cln3− cells do
display reduced cell-substrate and cell-cell adhesion, which
correlates with a decreased intracellular amount of the cell
adhesion protein contact site A (CsaA), and an increased
amount of soluble calcium-dependent cell adhesion mol-
ecule (CadA) in conditioned media [15] (Table 5). These re-
sults suggest that the reduced adhesion of cln3− cells to the
substrate and to each other causes the delayed and aberrant
aggregation. As proof-of-concept, aberrant adhesion has
also been observed in mammalian cells lacking functional
CLN3 (e.g., mouse cerebellar cells, human neuronal pro-
genitor cells derived from induced pluripotent stem cells
generated from patient fibroblasts) (Huber, Atwal,
Chandrachud, Cotman, unpublished observations). Finally,
during the mid-to-late stages of development, cln3− cells
develop precociously and cln3− slugs display enhanced
migration [13] (Table 5).
In Dictyostelium, Cln3 localizes to both the contractile
vacuole (CV) system and the endocytic pathway (late endo-
somes/lysosomes), and was detected in a proteomic profile
of the macropinocytic pathway [13, 15, 32] (Table 4). Like
other protists, the Dictyostelium CV system functions pri-
marily as an osmoregulatory organelle [48]. However roles
in ion homeostasis, vesicular trafficking, and unconven-
tional protein secretion have also been reported [48–50].
Importantly, defects in osmoregulation have been reported
in mammalian cell models lacking functional CLN3 [51–
53]. In Dictyostelium, the CV system is a major intracellular
store of ions, particularly calcium, and is required for
cAMP-mediated calcium influx during chemotaxis [48, 54–
56]. Calcium has also been shown to function as a chemo-
attractant during the early stages of Dictyostelium develop-
ment [57]. Moreover, the primary sensor of intracellular
calcium, calmodulin, localizes predominantly on the CV
system [50, 58]. Previous work has shown that Cln3-
deficiency phenotypes during development can be rescued
by chelating calcium with EGTA [13, 15]. More specifically,
calcium chelation rescues the aberrant streaming and ag-
gregation of cln3− cells, the precocious formation and en-
hanced migration of cln3− slugs, and the precocious
formation of cln3− fruiting bodies [13, 15]. These findings
suggest that cln3− cells may inappropriately buffer calcium
from the environment, and are consistent with studies in
mammalian systems that have reported altered ion homeo-
stasis, most notably calcium, in the absence of functional
CLN3 [59–64]. Given its localization to the CV system,
Dictyostelium presents an excellent system for studying the
possible function of Cln3 in calcium homeostasis. As dis-
cussed above, Cln3-deficiency alters the extracellular levels
of the cell proliferation regulators AprA and CfaD during
growth, and CadA during the early stages of development
[13, 15]. Intriguingly, CadA is secreted via an unconven-
tional pathway involving the CV system [65]. Coupled with
the localization of GFP-Cln3 to the CV system, these ob-
servations suggest that Cln3 may function to regulate un-
conventional protein secretion via the CV system during
Dictyostelium growth and development. Together these
results indicate that further study of Cln3 localization to
the CV system could provide valuable new insight into the
primary function of CLN3 in human cells.
In Dictyostelium, Cln3-deficiency causes pleiotropic ef-
fects that can be rescued through the expression of ei-
ther Dictyostelium Cln3 or human CLN3, thus
confirming that the function of CLN3 is evolutionarily
conserved [13, 15]. Moreover, the localization of Cln3 to
the CV system in Dictyostelium suggests that this model
organism could provide an excellent system for assessing
the role of the protein in osmotic stress, vesicular traf-
ficking, ion homeostasis, and unconventional protein se-
cretion. On a final note, Dictyostelium has been used as
a model system to study the virulence of Pseudomonas
aeruginosa, which is one of the most relevant human
opportunistic bacterial pathogens. Dictyostelium cells in-
fected with one of two strains of P. aeruginosa (PAO1
and PA14) cause a decrease in the expression of cln3
suggesting that Cln3 is also involved in the response of
Dictyostelium cells to bacterial pathogens [66] (Table 5).
Ddj1, the Dictyostelium homolog of DNAJC5/CLN4
Mutations in DNAJC5/CLN4 cause an adult-onset form
of NCL that is also known as Kufs disease or Parry dis-
ease [21, 23] (Table 1). DNAJC5 is conserved from yeast
to human and encodes cysteine-string protein alpha
(CSPα), which is a protein chaperone that localizes to
the cytoplasm and associates with vesicular membranes,
synaptic vesicles in neurons, and secretory granules in
endocrine, neurocrine, and exocrine cells [21, 27, 28]
(Tables 3 and 4). It has also been detected at the cell
membrane and in melanosomes [67, 68] (Table 4). The
disease-causing mutations in CSPα occur within the
highly conserved cysteine-string region that is respon-
sible for membrane binding and oligomerization [21].
The Dictyostelium homolog of DNAJC5, Ddj1 (DnaJ
homolog 1, DDB0215016), localizes to both the cytoplasm
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and cell cortex, and was detected in proteomic profiles of
the centrosome and macropinocytic pathway [32, 69]
(Tables 2 and 4). The ddj1 gene is composed of two exons
that encode a 411 amino acid, 46 kDa protein. ddj1 expres-
sion is highest during growth, the first 4 h of development,
and fruiting body formation [31] (Fig. 2c). Expression de-
creases substantially during aggregation reaching its lowest
level after 8 h of development, after which time the expres-
sion begins to increase (Fig. 2c). The peak expression level
occurs after 20 h of development (Fig. 2c). Together, these
observations suggest that the protein likely functions during
growth and terminal differentiation. A Dictyostelium ddj1
knockout mutant has not yet been generated, however the
function of the protein has been linked to phagocytosis in
Dictyostelium [70] (Table 5).
Cln5, the Dictyostelium homolog of human CLN5
Mutations in ceroid lipofuscinosis neuronal 5 (CLN5)
cause a late-infantile form of NCL [21, 23]. However, early
juvenile and adult cases have also been reported [71–73]
(Table 1). While this subtype had previously been referred
to as the Finnish variant, it now appears in other regions
of world [74]. The CLN5 protein localizes to the lysosomal
matrix, but has also been detected in conditioned media
from cultured cells [21, 75, 76] (Table 4). While the pre-
cise function of CLN5 in human cells is not known, it is
proposed to function in sphingolipid transport and syn-
thesis, myelination, cell growth, apoptosis, and the sorting
and recycling of lysosomal receptors [21] (Table 5). Like
CLN2, homologs of CLN5 do not exist in yeast, the nema-
tode, or the fruit fly (Table 3).
The Dictyostelium homolog of human CLN5, cln5, is
composed of three exons that encode a 322 amino acid,
37 kDa protein (Cln5; DDB0234077) (Table 2). While
the localization of Cln5 in Dictyostelium has not yet
been revealed, the protein was detected in a proteomic
analysis of the macropinocytic pathway [32] (Table 4).
Interestingly, like human CLN5, the Dictyostelium
homolog contains a signal peptide for secretion (SignalP
4.0) [39] and has been detected in conditioned media
from developing cells (Huber, manuscript in prepar-
ation). cln5 expression levels indicate that the protein
may play an important role during the early stages of de-
velopment [31] (Fig. 2c). Expression increases dramatic-
ally during the first 4 h of development, decreases
significantly during the next four hours, and then re-
mains low during the remaining stages of development
(Fig. 2c). Future work to generate and characterize a
cln5 knockout mutant should reveal Cln5-dependent
processes in Dictyostelium that may provide insight into
the precise function of the protein in human cells. This
is especially important considering that classical model
organisms such as yeast, the nematode, and the fruit fly
lack homologs of CLN5 (Table 3).
Mfsd8, the Dictyostelium homolog of human MFSD8/CLN7
Mutations in major facilitator superfamily domain-
containing protein 8 (MFSD8), also known as CLN7,
cause a late-infantile form of NCL that was previously
referred to as the Turkish variant [21, 23] (Table 1). The
protein, which contains 12 transmembrane domains, lo-
calizes to the lysosomal membrane and is predicted to
play a role in the transport of small substrates across the
lysosomal membrane [21] (Tables 4 and 5). However, the
precise function of the protein and its substrates are still
not known. Homologs of MFSD8 are present in the
nematode, the fruit fly, and zebrafish, but absent in yeast
[27, 28] (Table 3).
The Dictyostelium homolog of human MFSD8, mfsd8,
is composed of one exon that encodes a 498 amino acid,
55 kDa protein (Mfsd8; DDB0307149) (Table 2). Prote-
omic analyses have localized the protein to the macropi-
nocytic pathway [32] (Table 4). Although a knockout
mutant has not yet been generated in Dictyostelium,
RNA-seq studies have provided some insight into when
during the life cycle the protein may function. mfsd8 ex-
pression increases during the first 8 h of development
[31] (Fig. 2b) suggesting that the protein functions dur-
ing cAMP chemotaxis and aggregation. Expression then
decreases between 8 and 20 h before rising slightly dur-
ing fruiting body formation (Fig. 2b). By generating and
characterizing a Dictyostelium mfsd8 knockout mutant,
future research may be able to provide insight into the
primary function of MFSD8 that is lost in NCL patients.
CtsD, the Dictyostelium homolog of human CTSD/CLN10
Mutations in cathepsin D (CTSD), also known as
CLN10, have been linked to aging and neurodegenera-
tion, including congenital, neonatal, and late infantile
forms of NCL [21, 23, 77] (Table 1). Juvenile forms of
this NCL subtype have also been reported [78]. CTSD is
an aspartic protease that is conserved from yeast to hu-
man [26–28] (Table 3). It localizes to the lysosomal
matrix and is linked to aberrant apoptosis and autoph-
agy [21] (Tables 4 and 5). The enzyme, which contains a
peptidase A1 domain and a signal peptide for secretion,
has also been detected extracellularly, where its function
is linked to a number of human cancers (SignalP 4.0)
[39, 79] (Table 4). Proteomic profiling has also detected
extracellular CTSD in aortic samples, where it was
found to be loosely bound to the matrix [80] (Table 4).
The Dictyostelium homolog of human CTSD, ctsD, is
composed of two exons that encode a 383 amino acid, 41
kDa protein (CtsD; DDB0215012) that is present through-
out the endocytic pathway, including maturing phago-
somes and lysosomes [32, 81–83] (Tables 2 and 4). Like
human CTSD, the Dictyostelium homolog contains a sig-
nal peptide for secretion (SignalP 4.0) [39] and has been
detected in conditioned media from developing cells
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(Huber, manuscript in preparation). The mRNA expres-
sion profile of ctsD indicates that the protein functions
primarily during growth, where its expression in the high-
est [31] (Fig. 2d). ctsD expression decreases dramatically
during the first four hours of development before rising
slightly between 4 and 8 h (Fig. 2d). Expression then
steadily decreases during the remaining stages of develop-
ment (Fig. 2d). ctsD− cells display no overt phenotypes
during growth or development, except for a slight delay in
aggregation [81] (Table 5). Interestingly, ctsD expression is
downregulated 10-fold in srfB− cells [84]. SrfB (serum re-
sponse factor B) is a DNA-binding protein that similar to
ctsD, is expressed in growth-phase cells as well as during
the later stages of aggregation [84]. srfB− cells display de-
creased proliferation, aberrant cytokinesis, increased pino-
cytosis, abolished streaming, and precocious aggregation
[84]. The defects in streaming and aggregation can be res-
cued by manually stimulating cells with pulses of cAMP
suggesting that cAMP signaling is aberrant in srfB− cells
[84]. These phenotypes, coupled with the similar expres-
sion profiles of srfB and ctsD, the dramatic reduction in
the expression of ctsD in srfB− cells, and the delayed ag-
gregation of ctsD− cells suggest that CtsD is required for
optimal migration and aggregation in Dictyostelium. This
is supported by studies in mammalian cells that have re-
ported reduced migration of CTSD-deficient cells due to
aberrant organization of cytoskeletal components, which
if present in neurons, could have negative effects on
neurogenesis, maintenance of neuronal polarity and shape,
and migration [85] (Table 5).
In addition to studies on SrfB function, other work in
Dictyostelium has also provided insight into CtsD function,
specifically its role in bacterial killing and cell death. Dur-
ing infection with Salmonella typhimurium, the agent of
food-borne gastroenteritis, Dictyostelium cells activate a
defense response involving the upregulation of a number
of cysteine proteases and cathepsins, including CtsD [86]
(Table 5). Interestingly, studies in mice have linked CTSD
function to the innate immune response against Listeria
monocytogenes [87]. In Dictyostelium, research suggests
that CtsD is involved in staurosporine-induced cell death
and functions with calpains to facilitate cell dismantling
during oxidative stress-induced cell death [88, 89] (Table 5).
Intriguingly, CTSD is linked to staurosporine-induced
apoptosis in human fibroblasts and activates autophagy to
inhibit oxidative stress-induced cell death in human cancer
cells [90, 91]. Staurosporine induces apoptosis in a number
of mammalian cell lines, activating both caspase-
dependent and caspase-independent types of cell death
[92]. Caspase-independent cell death occurs through the
release of lysosomal enzymes into the cytosol [93]. This is
significant since the Dictyostelium genome does not en-
code caspases and instead undergoes caspase-independent
cell death, which results in the release of lysosomal
enzymes such as CtsD into the cytoplasm [94, 95]. To-
gether, these results have provided insight into the func-
tions of CtsD during the Dictyostelium life cycle. Future
research using this model organism may be able to assess
the effects of NCL-causing CTSD mutations on CtsD-
dependent processes in Dictyostelium.
Grn, the Dictyostelium homolog of human PGRN/CLN11
Mutations in PGRN (progranulin), also referred to as
CLN11, cause an adult-onset form of NCL in humans
[21, 23] (Table 1). Interestingly, heterozygote mutations
in PGRN also cause frontotemporal dementia [96].
PGRN is a multi-domain protein that is secreted and
proteolytically cleaved to generate 6-kDa cleavage prod-
ucts called granulins (GRNs) (1–7) [21, 97] (Table 4).
The primary functions of GRNs are still not known,
however they are proposed to function in autophagy,
embryogenesis, cell motility, inflammation, and tumori-
genesis [21, 97] (Table 5). Homologs of GRNs are
present in the nematode and zebrafish, but absent in
yeast and the fruit fly [27, 28] (Table 3).
The Dictyostelium homolog of human GRN, Grn, is
highly similar in sequence to human GRNs 1–7 (Table 2).
The grn gene is composed of two exons that encode a 130
amino acid, 14 kDa protein (Grn; DDB0238428). The
mRNA expression profile of grn indicates that the protein
likely functions during growth where its expression is the
highest [31] (Fig. 2b). Expression then decreases dramatic-
ally during development reaching its lowest level between
16 and 24 h suggesting that it may not be required for pro-
cesses that occur during the mid-to-late stages of Dictyos-
telium development (e.g., terminal differentiation) (Fig. 2b).
Although a grn knockout mutant has not yet been gener-
ated, future work aimed at creating a Dictyostelium Grn-
deficiency model may be able to provide insight into the
primary function of GRNs, and how mutations in PGRN
cause NCL and frontotemporal dementia in humans.
Kil2, the Dictyostelium homolog of human ATP13A2/
CLN12
Another juvenile-onset form of NCL is caused by muta-
tions in ATP13A2, which is also known as CLN12 [21, 23]
(Table 1). ATP13A2 contains 10 transmembrane domains
and belongs to a family of P-type ATPases that are in-
volved in the active transport of cations, heavy metals, and
lipids across cellular membranes [98]. ATP13A2 is con-
served from yeast to human and localizes to the lysosomal
membrane and multi-vesicular bodies [21, 27, 28, 99, 100]
(Tables 3 and 4). The precise function of the protein is not
yet known however it is predicted to transport heavy
metals, cations, and lipids across cellular membranes, and
to be involved in degrading material and maintaining pH
and biometal homeostasis within lysosomes [21] (Table 5).
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Interestingly, ATP13A2 also protects against α-synuclein
toxicity in several models of Parkinson’s disease [101].
The Dictyostelium homolog of ATP13A2 is Kil2
(DDB0237611), which is a V-type P-ATPase that contains
10 transmembrane domains [102] (Table 2). The kil2 gene
is composed of two exons that encode an 1158 amino
acid, 131 kDa protein that localizes to the phagosomal
membrane and is present in the macropinocytic pathway
[32, 102] (Table 4). The mRNA expression profile of kil2
suggests that the protein functions primarily during devel-
opment, specifically during terminal differentiation. Ex-
pression increases steadily during development reaching
peak levels during fruiting body formation [31] (Fig. 2b).
Dictyostelium serves as an excellent model system for
studying the cellular mechanisms involved in the degrad-
ation of ingested bacteria and yeast [103, 104], and previ-
ous work investigating this process has provided some
insight into the function of Kil2. In humans, the efficient
ingestion and killing of bacteria by phagocytic cells is ne-
cessary to protect the human body from infectious micro-
organisms. Kil2-deficient cells show reduced phagosomal
activity compared to wild-type cells and are not able to kill
ingested Klebsiella pneumoniae bacteria [102, 105]
(Table 5). However these defects can be restored by sup-
plementing the medium with magnesium suggesting that
Kil2 functions as a magnesium pump to maintain the opti-
mal concentration of magnesium in phagosomes, and to
ensure the activity of phagosomal proteases [102]. Intri-
guingly, kil2− cells are still able to kill several other species
of bacteria (e.g., B. subtilis and P. aeruginosa) suggesting
that the response of cells to ingested bacteria likely in-
volves a diversity of proteins with different specificities
[102]. More recently, Kil2 function has also been linked to
the predation of Dictyostelium amoeba on yeast [104].
Since Kil2 appears to function as a magnesium pump in
Dictyostelium, and ATP13A2 is proposed to function in
maintaining biometal homeostasis in human lysosomes,
these results support the use of Dictyostelium as a model
system for studying the function of this protein. Thus, fu-
ture work in Dictyostelium may be able to provide new
insight into the function of ATP13A2 in humans and how
mutations in this gene cause NCL.
CprA, the Dictyostelium homolog of human CTSF/CLN13
Mutations in cathepsin F (CTSF), also known as CLN13,
have been linked to another adult-onset form of NCL
[21, 23] (Table 1). CTSF is a cysteine protease that
belongs to the peptidase C1 family of proteases. The
protein localizes to the lysosomal matrix, and has been
proposed to function in autophagy, proteasome degrad-
ation, cell immunity, and lipoprotein degradation [21]
(Tables 4 and 5). CTSF contains a signal peptide for se-
cretion and has been detected extracellularly (SignalP
4.0) [39, 106] (Table 4). Homologs of CTSF are present
in the nematode, the fruit fly, and zebrafish, but absent
in yeast [27, 28] (Table 3).
CprA (cysteine proteinase A; DDB0201647) is the Dic-
tyostelium homolog of human CTSF (Table 2). The gene,
which shares a high degree of homology to plant and ani-
mal sulphydryl proteinases, is composed of six exons that
encode a 343 amino acid, 39 kDa protein [107]. cprA is
not expressed during the growth phase of the life cycle
[31]. However, its expression, which is inducible by extra-
cellular cAMP, increases dramatically during the early
stages of development [31, 108] (Fig. 2d). By 10–12 h,
cprA mRNA comprises approximately 1% of the total cel-
lular mRNA [109]. While the expression of cprA steadily
decreases during the remaining stages of development,
cprA has been identified as a pre-stalk specific gene [31,
46, 109] (Fig. 2d). It has been suggested that CprA func-
tions to digest proteins during development to provide
amino acids and a source of energy for developing cells
[109]. A cprA knockout mutant has not yet been gener-
ated however previous studies have provided some insight
into the function of the protein. cprA expression was
shown to be induced during hyperosmotic stress with 200
mM sorbitol suggesting that protein functions during the
osmotic stress response [110] (Table 5). cprA expression is
also upregulated in rpkA− cells during starvation [111].
RpkA (receptor phosphatidylinositol kinase A) is seven-
transmembrane G-protein coupled receptor (GPCR) that
contains a C-terminal phosphatidylinositol-4-phosphate
5-kinase (PIP5K) domain (http://www.dictybase.org). Im-
portantly, RpkA localizes to late phagosomes and is in-
volved in the phagocytosis of infectious bacteria [112],
which adheres to the proposed function of CTSF in cell
immunity in mammalian cells [113] (Table 5). At low
density, rpkA− cells fail to aggregate due to their inability
to respond to cAMP and conditioned media factor (CMF)
[111]. Given the increased expression of cprA in rpkA−
cells, and the dramatic increase in expression of cprA dur-
ing the early stages of development, these results suggest
that CprA is required for cAMP chemotaxis and aggrega-
tion in Dictyostelium. Finally, like human CTSF, CprA
contains a signal peptide for secretion and has been
detected in conditioned media from developing cells
(SignalP 4.0) [39] (Huber, manuscript in preparation).
Together, these results have provided insight into the
function of CprA during the Dictyostelium life cycle.
Further examination of its localization in Dictyostelium,
and the creation of a CprA-deficiency model, may be able
to provide additional insight into the role of CTSF in
human disease.
Kctd9, the Dictyostelium homolog of human KCTD7/
CLN14
Mutations in potassium channel tetramerization-domain
7 (KCTD7), also known as CLN14, have been linked to
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another infantile form of NCL [21, 23, 114] (Table 1). In
humans, the KCTD family of proteins consists of 26
members with mostly unknown functions [115]. Muta-
tions in KCTD7 cause vision loss, progressive myoclonic
epilepsy, progressive decline in cognition and motor
skills, and a reduced lifespan [114]. NCL-type storage
material is also observed in patient samples [114]. In a
wild-type mouse cerebellar cell line, KCTD7 fused to
GFP localizes to the cell membrane, as well as punctate
distributions within the cytoplasm [114] (Table 4). The
precise function of the protein is not yet known however
it is predicted to be involved in proteasome degradation
and hyperpolarization of the neuronal cell membrane
[21] (Table 5). Homologs of KCTD7 are present in the
nematode, the fruit fly, and zebrafish, but absent in yeast
[27, 28] (Table 3).
Kctd9 (DDB0231824) is the Dictyostelium homolog
of human KCTD7 (Table 2). The protein contains
four penta-peptide repeats, a double-courtin domain,
and is highly similar to vertebrate potassium channel
tetramerization domain-containing proteins. The gene
is composed of one exon that encodes a 488 amino
acid, 53 kDa protein. The mRNA expression profile
of kctd9 suggests that the protein functions during
the mid-stages of development. kctd9 expression
decreases during the early stages of development
reaching its lowest level after 4 h [31] (Fig. 2b). Ex-
pression then increases significantly to reach its peak
level after 12 h, and is followed by a steady decrease
in expression between 12 and 24 h of development
(Fig. 2b). Although the effect of Kctd9-deficiency dur-
ing growth and development has not yet been stud-
ied, gene expression studies have provided some
insight into its function during sexual development.
In addition to the asexual life cycle, Dictyostelium can
also undergo sexual reproduction to form macrocysts
[116]. During this alternative life cycle, phermonal
interactions generate fusion-competent cells, which
then undergo cell and pronuclear fusion through a
process involving cAMP chemotaxis. kctd9− cells
show no obvious phenotypes during macrocyst forma-
tion, however kctd9 expression is enriched in gametes
(e.g., sexually mature, fusion-competent cells) [117, 118]
suggesting that the protein may be involved in mem-
brane fusion during sexual development. The research
community would benefit from future work examin-
ing the precise function of Kctd9 during membrane
fusion as well as examining the effect of Kctd9 loss
on processes that occur during the Dictyostelium
asexual life cycle.
Conclusions
Accumulated evidence indicates that Dictyostelium
could provide unprecedented opportunities to elucidate
the normal functions of NCL proteins and the signal
transduction regulating their activities. This is especially
true for those proteins that have no clear homologs in
other classical model organisms. Many of the NCL ho-
mologs in Dictyostelium were detected in a proteomic
profile of the macropinocytic pathway, which supports
the suggestion that NCL proteins share common func-
tions or participate in the same biological pathway or
process [32, 119] (Table 4). While the functions of some
of the NCL homologs in Dictyostelium have been previ-
ously studied, many have not been investigated in rela-
tion to human disease. A major benefit of using
Dictyostelium to study NCL protein function is the abil-
ity to knockout multiple genes in a single cell line using
homologous recombination [120]. Importantly, this al-
lows researchers to study epistatic relationships between
genes and will allow future studies to assess potential
functional redundancies between the NCL homologs in
Dictyostelium. However, one must acknowledge that
using Dictyostelium as model system for studying NCL
protein function does present some limitations. For in-
stance, while Dictyostelium does develop into a true
multicellular organism, it contains a limited number of
cell types that may present challenges when attempting
to relate gene-deficiency phenotypes in Dictyostelium to
pathologies in specific tissues or organs in humans.
Since Dictyostelium lacks a central nervous system, dis-
coveries made in Dictyostelium must be evaluated in the
relevant mammalian cell type. Nonetheless, the ability of
human NCL proteins to rescue deficiency phenotypes in
Dictyostelium [13–15] suggests that the biological path-
ways regulating the functions of NCL proteins are likely
conserved from Dictyostelium to human. In addition to
normal function models, future studies can use Dictyos-
telium to assess the effects of newly discovered muta-
tions on NCL protein function, which will greatly
improve our understanding of the molecular basis of the
NCL disorders, and will hopefully aid in the develop-
ment of therapies that rescue the molecular defects in
NCL patients.
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